In Vitro Enzymatic and Kinetic Studies, and In Silico Drug-Receptor Interactions, and Drug-Like Profiling of the 5-styrylbenzamide Derivatives as Potential Cholinesterase and β-secretase Inhibitors with Antioxidant Properties
The 5-(styryl)anthranilamides were transformed into the corresponding 5-styryl-2-(<i>p</i>-tolylsulfonamido)benzamide derivatives. These 5-styrylbenzamide derivatives were evaluated through enzymatic assays in vitro for their capability to inhibit acetylcholinesterase (AChE), butyrylchol...
Main Authors: | Malose J. Mphahlele, Emmanuel N. Agbo, Garland K. More, Samantha Gildenhuys |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/10/5/647 |
Similar Items
-
Synthesis and Evaluation of the 4-Substituted 2-Hydroxy-5-Iodochalcones and Their 7-Substituted 6-Iodoflavonol Derivatives for Inhibitory Effect on Cholinesterases and β-Secretase
by: Malose J. Mphahlele, et al.
Published: (2018-12-01) -
Inhibitory Effects of Novel 7-Substituted 6-iodo-3-<i>O</i>-Flavonol Glycosides against Cholinesterases and β-secretase Activities, and Evaluation for Potential Antioxidant Properties
by: Emmanuel N. Agbo, et al.
Published: (2019-09-01) -
In Vitro Evaluation and Docking Studies of 5-oxo-5<i>H</i>-furo[3,2-<i>g</i>]chromene-6-carbaldehyde Derivatives as Potential Anti-Alzheimer’s Agents
by: Malose J. Mphahlele, et al.
Published: (2019-11-01) -
Cholinesterase inhibitors influence APP metabolism in Alzheimer disease patients
by: Martina Zimmermann, et al.
Published: (2005-06-01) -
Development of a beta-Secretase Activated Prochelator and FRET Probe to Mediate Copper Toxicity in Alzheimer's Disease
by: Folk, Drew Steven
Published: (2012)